AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea flag South Korea · Delayed Price · Currency is KRW
66,500
+3,300 (5.22%)
At close: Mar 6, 2026

AprilBio Revenue

AprilBio had revenue of 8.97B KRW in the twelve months ending September 30, 2025, down -56.67% year-over-year. In the year 2024, AprilBio had annual revenue of 27.51B.

Revenue (ttm)
8.97B
Revenue Growth
-56.67%
P/S Ratio
159.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,433.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202427.51B--
Dec 31, 2023---
Dec 31, 2022200.00M-23.20B-99.15%
Dec 31, 202123.40B--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Qurient 8.28B
JS Link 16.14B
ROKIT Healthcare 20.33B
HansBiomed 100.17B
IntoCell 1.68B
Aimed Bio 29.65B
S.Biomedics 16.96B
Y-Biologics 3.61B
Revenue Rankings